Literature DB >> 16597901

Fulminant, acyclovir-resistant, herpes simplex virus type 2 hepatitis in an immunocompetent woman.

Todd Czartoski1, Charlie Liu, David M Koelle, Stephen Schmechel, Andrea Kalus, Anna Wald.   

Abstract

We report an immunocompetent woman with multisystem organ failure following herpes simplex virus type 2 (HSV-2) hepatitis. After she initially responded to intravenous acyclovir, she was switched to oral valacyclovir. She developed respiratory failure and opportunistic infections and died. Autopsy confirmed disseminated HSV infection, and lung tissue grew acyclovir-resistant HSV-2.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16597901      PMCID： PMC1448683          DOI： 10.1128/JCM.44.4.1584-1586.2006

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  22 in total

1.  Detection of herpes simplex virus DNA in the peripheral blood during acute recurrent herpes labialis.

Authors:  S L Brice; S S Stockert; J D Jester; J C Huff; J D Bunker; W L Weston
Journal:  J Am Acad Dermatol       Date:  1992-04       Impact factor: 11.527

2.  Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients.

Authors:  A Gaudreau; E Hill; H H Balfour; A Erice; G Boivin
Journal:  J Infect Dis       Date:  1998-08       Impact factor: 5.226

3.  Viremia in neonatal herpes simplex virus infections.

Authors:  C Diamond; K Mohan; A Hobson; L Frenkel; L Corey
Journal:  Pediatr Infect Dis J       Date:  1999-06       Impact factor: 2.129

4.  Fulminant hepatitis during herpes simplex virus infection in apparently immunocompetent adults: report of two cases and review of the literature.

Authors:  R W Farr; S Short; D Weissman
Journal:  Clin Infect Dis       Date:  1997-06       Impact factor: 9.079

5.  The genome sequence of herpes simplex virus type 2.

Authors:  A Dolan; F E Jamieson; C Cunningham; B C Barnett; D J McGeoch
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

6.  Genetic characterization of thymidine kinase from acyclovir-resistant and -susceptible herpes simplex virus type 1 isolated from bone marrow transplant recipients.

Authors:  F Morfin; G Souillet; K Bilger; T Ooka; M Aymard; D Thouvenot
Journal:  J Infect Dis       Date:  2000-06-19       Impact factor: 5.226

7.  Fulminant herpes hepatitis in a healthy adult: a treatable disorder?

Authors:  M Velasco; E Llamas; M Guijarro-Rojas; M Ruiz-Yagüe
Journal:  J Clin Gastroenterol       Date:  1999-06       Impact factor: 3.062

Review 8.  Herpes simplex virus hepatitis: case report and review.

Authors:  B Kaufman; S A Gandhi; E Louie; R Rizzi; P Illei
Journal:  Clin Infect Dis       Date:  1997-03       Impact factor: 9.079

9.  Survey of acyclovir-resistant herpes simplex virus in the Netherlands: prevalence and characterization.

Authors:  Růzena Stránská; Rob Schuurman; Elske Nienhuis; Irma W Goedegebuure; Merjo Polman; Jan F Weel; Pauline M Wertheim-Van Dillen; Ron J M Berkhout; Anton M van Loon
Journal:  J Clin Virol       Date:  2005-01       Impact factor: 3.168

10.  Nonfatal disseminated mucocutaneous herpes simplex type 2 infection in a healthy woman.

Authors:  D H Gutmann; B A Beard; M L Collinge
Journal:  Obstet Gynecol       Date:  1988-09       Impact factor: 7.661
View more
  18 in total

Review 1.  Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management.

Authors:  Jocelyne Piret; Guy Boivin
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

2.  Developing an asymptomatic mucosal herpes vaccine: the present and the future.

Authors:  Gargi Dasgupta; Anthony B Nesburn; Steven L Wechsler; Lbachir BenMohamed
Journal:  Future Microbiol       Date:  2010-01       Impact factor: 3.165

3.  Quantification of viral DNA and liver enzymes in plasma improves early diagnosis and management of herpes simplex virus hepatitis.

Authors:  M F C Beersma; G M G M Verjans; H J Metselaar; A D M E Osterhaus; W R Berrington; G J van Doornum
Journal:  J Viral Hepat       Date:  2010-08-12       Impact factor: 3.728

4.  Use of acyclovir for suppression of human immunodeficiency virus infection is not associated with genotypic evidence of herpes simplex virus type 2 resistance to acyclovir: analysis of specimens from three phase III trials.

Authors:  Deborah Watson-Jones; Anna Wald; Connie Celum; Jairam Lingappa; Helen A Weiss; John Changalucha; Kathy Baisley; Clare Tanton; Richard J Hayes; Joshua O Marshak; Rula Green Gladden; David M Koelle
Journal:  J Clin Microbiol       Date:  2010-08-11       Impact factor: 5.948

5.  Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials.

Authors:  Christine Johnston; Misty Saracino; Steve Kuntz; Amalia Magaret; Stacy Selke; Meei-Li Huang; Joshua T Schiffer; David M Koelle; Lawrence Corey; Anna Wald
Journal:  Lancet       Date:  2012-01-04       Impact factor: 79.321

6.  Diverse herpes simplex virus type 1 thymidine kinase mutants in individual human neurons and Ganglia.

Authors:  Kening Wang; Gowtham Mahalingam; Susan E Hoover; Erik K Mont; Steven M Holland; Jeffrey I Cohen; Stephen E Straus
Journal:  J Virol       Date:  2007-04-25       Impact factor: 5.103

7.  Clinical correlates of herpes simplex virus viremia among hospitalized adults.

Authors:  William R Berrington; Keith R Jerome; Linda Cook; Anna Wald; Lawrence Corey; Corey Casper
Journal:  Clin Infect Dis       Date:  2009-11-01       Impact factor: 9.079

8.  Chemistry and anti-herpes simplex virus type 1 evaluation of 4-substituted-1H-1,2,3-triazole-nitroxyl-linked hybrids.

Authors:  Anna C Cunha; Vitor F Ferreira; Maria G F Vaz; Rafael A Allão Cassaro; Jackson A L C Resende; Carolina Q Sacramento; Jéssica Costa; Juliana L Abrantes; Thiago Moreno L Souza; Alessandro K Jordão
Journal:  Mol Divers       Date:  2020-05-06       Impact factor: 2.943

9.  Synthesis and Evaluation of Some Uracil Nucleosides as Promising Anti-Herpes Simplex Virus 1 Agents.

Authors:  Samir Mohamed Awad; Shima Mahmoud Ali; Yara Essam Mansour; Samar Said Fatahala
Journal:  Molecules       Date:  2021-05-18       Impact factor: 4.411

Review 10.  Mucosal herpes immunity and immunopathology to ocular and genital herpes simplex virus infections.

Authors:  Aziz Alami Chentoufi; Lbachir Benmohamed
Journal:  Clin Dev Immunol       Date:  2012-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.